B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesImmunogenicity of protein therapeutics: The key causes, consequences and challengesDirect Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint diseaseImmunogenicity of Biotherapeutics: Causes and Association with Posttranslational ModificationsHib Vaccines: Past, Present, and Future PerspectivesPolyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesRegulation of Aicda expression and AID activityFactors regulating immunoglobulin production by normal and disease-associated plasma cellsA review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.Directing the immune response to carbohydrate antigens.The unique immunological features of heparin-induced thrombocytopenia.Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoA self-assembling peptide acting as an immune adjuvant.The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsUpregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotesEvaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.Molecular cloning of a new immunomodulatory protein from Anoectochilus formosanus which induces B cell IgM secretion through a T-independent mechanismIncreased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide.Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administrationImmunogenicity to biologics: mechanisms, prediction and reduction.Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaSystemic effects of periodontal disease in cats.HIV p24 as scaffold for presenting conformational HIV Env antigens.B1b cells recognize protective antigens after natural infection and vaccination.Control of Toll-like receptor-mediated T cell-independent type 1 antibody responses by the inducible nuclear protein IκB-ζTumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner.Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesiclesToll-like receptor 2 and Toll-like receptor 4-dependent activation of B cells by a polysaccharide from marine fungus Phoma herbarum YS4108The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.Killer B lymphocytes and their fas ligand positive exosomes as inducers of immune toleranceT lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.Hybrid flagellin as a T cell independent vaccine scaffoldDesign considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensIntracellular calcium signals and control of cell proliferation: how many mechanisms?Genomics of immune response to typhoid and cholera vaccinesInflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults
P2860
Q24624348-F261B457-89AE-4272-A1D9-4A7EC81BA89CQ24633296-88E89F6E-9F17-44FA-8221-788678543F5DQ24796731-A837435D-52BE-42FC-9F73-B02054A2ED63Q26738810-4AE8D5EF-B90B-4708-84EA-CF6AE3A99F4AQ26767144-63CD9B1E-3437-42A2-9595-D1A0FD9CAC6CQ26852816-EA98D93E-1E05-48FE-B933-5DC9F7976481Q26853622-64930C19-0452-4E1D-AB37-5E46FADA3A0CQ27021855-40A099F8-A28C-413B-A235-E4111569BC34Q30217185-6697A42E-090D-4602-91AA-3A5947107B9AQ30672149-43735232-23F4-4129-A331-07D310F5EBA6Q33440626-D1E5A89F-C7DC-4300-9ECB-9F0C91B05AB2Q33615157-33B7C64B-9BDF-4CBF-9A9F-9873E918D19EQ33640064-BA67518F-3341-4D7C-937E-E3AD68FB2880Q33685257-AD0B3F25-B42E-49DC-B42C-9DA57FFFBC0DQ33721641-8E29FBCF-385C-4F29-A0D2-40525FE1D9D2Q33826124-37F09964-0CEE-4A28-9AA8-79073AB73670Q33847250-90D2952F-8389-4FED-9A1B-AC5FDACEA1C0Q33893517-FE406A66-269D-4585-A8E8-1FE1D3D7954DQ33901610-A13E39F3-DB2D-4F03-B6C2-E95D22F8F2F8Q33941018-E927EEDF-7D63-4BDA-AD78-6DEF552F986AQ34007255-3DFBCC32-A727-478D-A34F-B3B13F6B1678Q34064079-8DF045C0-B2C8-4D7D-A84C-D4F46542590FQ34296526-13FA6A36-5811-408B-8A90-ED9AA70F9F82Q34301187-C9BA382C-2B2D-4B8C-8306-3004C98DB91EQ34314441-00B117FB-730B-413A-A7C3-D63661184EC8Q34389522-EE17A07A-86B0-4C28-984B-131B373310A5Q34433081-55565F7D-4DC7-450E-9610-2357685A08CCQ34467437-115B5375-0491-4D5C-9625-311D9B0FD89CQ34551535-A4D083ED-AE22-44C9-AE2C-EB907493DD88Q34576021-3432CCEB-CCC6-4050-8632-88E34BEBFD4FQ34654099-85EF2739-C55A-4C76-BD35-966B6329502CQ34894134-8775D002-2EAC-4401-8D61-EA30FD8F9996Q34992090-119AB07E-152D-469F-B7D9-503F4811AB34Q35199945-C8BEFD30-EABA-4359-AAB1-6E2A09CFE0C4Q35608835-4241835A-DE10-4E19-9266-515B80B48EECQ35743398-41B6786C-1987-4963-95A3-D43684304313Q35812875-20165FBA-7FC5-4391-B537-3E182F9CFB30Q35837754-D75EF62F-CA4B-467B-B994-69601ABCFB92Q35923828-7C6FF90F-B6BC-4BEF-AA92-588A839B757EQ35940864-E1DCAAB8-EEC5-48E3-B7A9-A1AFFDEAF815
P2860
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@ast
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@en
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@nl
type
label
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@ast
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@en
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@nl
prefLabel
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@ast
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@en
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@nl
P2093
P1476
B-cell activation by T-cell-in ...... to pathogenic microorganisms.
@en
P2093
P304
P356
10.1034/J.1600-065X.2000.00607.X
P577
2000-08-01T00:00:00Z